Your browser doesn't support javascript.
loading
Salvage transoral robotic surgery in early-stage oropharyngeal recurrence.
Asairinachan, Ashwinna; O'Duffy, Fergal; Fua, Tsien; Magarey, Matthew J R; Dixon, Benjamin J.
Afiliación
  • Asairinachan A; Department of Surgical Oncology, Head & Neck Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Electronic address: Ash.asair@gmail.com.
  • O'Duffy F; Department of Surgical Oncology, Head & Neck Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Fua T; Department of Radiation Oncology, Peter MacCallum Cancer Centre.
  • Magarey MJR; Department of Surgical Oncology, Head & Neck Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Head & Neck Surgery, Epworth Healthcare, Richmond, Victoria, Australia.
  • Dixon BJ; Department of Surgical Oncology, Head & Neck Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Head & Neck Surgery, Epworth Healthcare, Richmond, Victoria, Australia.
Article en En | MEDLINE | ID: mdl-33744203
OBJECTIVES: Limited data are currently available regarding outcomes following transoral robotic surgery (TORS) in the salvage setting. This study aims to investigate the functional and oncological outcomes following TORS in salvage oropharyngeal tumors. STUDY DESIGN: All patients undergoing salvage TORS for a residual, recurrent, or new primary oropharyngeal squamous cell carcinoma within a previously radiated field between March 2014 and October 2018 were included. Patients undergoing salvage TORS for other subsites were excluded. Margin status, complication rates, long-term tracheostomy, and gastrostomy requirements and overall and disease-free survival outcomes were recorded. RESULTS: A total of 26 patients were included. Three patients (11%) experienced a TORS-specific major complication. A gastrostomy tube was required in 42% of patients on discharge (n = 11), and in 28% of patients on long-term follow-up (n = 7) at a median of 34 (interquartile range, 11.8-47.8) months. A tracheostomy was placed in 5 patients and all were removed before discharge. The 3-year overall survival and disease-free survival were 74% and 70%, respectively. CONCLUSION: Salvage TORS is a viable and effective option in the management of selected tumors within a previously radiated field.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias Orofaríngeas / Procedimientos Quirúrgicos Robotizados / Neoplasias de Cabeza y Cuello Límite: Humans Idioma: En Revista: Oral Surg Oral Med Oral Pathol Oral Radiol Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias Orofaríngeas / Procedimientos Quirúrgicos Robotizados / Neoplasias de Cabeza y Cuello Límite: Humans Idioma: En Revista: Oral Surg Oral Med Oral Pathol Oral Radiol Año: 2021 Tipo del documento: Article